Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments

Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations.The collaboration continues a successful partnership on evaluating new treatment regimens aimed …
Jetzt den vollständigen Artikel lesen